Key Highlights
• ATEC shares rose 3.06% intraday to $8.92 on above-average volume.
• The stock benefited from a broader sector rotation into healthcare and medical technology names.
• Consensus price targets for the stock range from $11 to $24, well above current trading levels.
• Alphatec reported fiscal 2024 revenue of approximately $612 million, up 27% year over year.
Medtech Rotation Lifts Shares
Alphatec Holdings, Inc. (NASDAQ:ATEC) shares gained Wednesday on above-average volume amid a broader rotation into healthcare and medical technology stocks, as investors pivoted away from technology sector volatility. The medtech space has seen renewed interest following a period of aggressive sector rotation out of large-cap technology names.
Alphatec is a Carlsbad, California-based medical technology company focused exclusively on spine surgery, operating through subsidiaries that design and commercialize spinal implants, biologics, access technologies and enabling platforms, including its AlphaInformatiX system integrating imaging, neural monitoring and navigation.
Bullish Price Targets Persist Despite Trims
Wall Street consensus remains firmly bullish on Alphatec, with price targets ranging from $11 to $24, well above current trading levels, despite some targets being trimmed earlier this year alongside broader medtech valuation multiple compression. Alphatec reported fiscal 2024 total revenue of approximately $612 million, a 27% year-over-year increase, driven by strong surgical product adoption, with the company projecting continued growth toward approximately $733 million in the following year.
Conclusion
The rotation into healthcare and medtech names, combined with continued bullish consensus price targets, has provided a supportive backdrop for Alphatec shares. With the stock trading well below analyst price target ranges, continued execution on its spine-focused growth strategy will be key to closing that valuation gap.
This article is for informational purposes only and does not constitute investment advice. Readers should conduct their own research before making financial decisions.






Please wait processing your request...